# Actuate Therapeutics, Inc.: insider transactions

ACTU · Nasdaq · CIK 1652935 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/actu.md) · [Financials](/companies/actu/financials.md) · [Filings](/companies/actu/filings.md) · [Insiders](/companies/actu/insiders.md)

## All transactions: 1

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-28 | [Schmitt Daniel M](/insiders/1318470.md) | President, CEO and Director, Director, Officer | Purchase (P) | 140,844 | $0.355 | $50.0k | [Form 4](/filings/0001683168-26-008147.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 17:14 ET. No prices; not investment advice.